Bipolar affective disorder is a common neuropsychiatric disorder. Although its
neurobiological underpinnings are incompletely understood, the dopamine hypothesis has …

Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval …

This paper reviews the findings from preclinical animal and human clinical research
investigating maternal/fetal, neonatal, and child neurodevelopmental outcomes following …

Objectives The aim of the present study was to describe prescription patterns and changes
in these patterns over the last decade for patients diagnosed with bipolar disorder in mental …

Mental disorders (MDs) are highly prevalent and potentially debilitating complex disorders
which causes remain elusive. Looking into deeper aspects of etiology or pathophysiology …

Background Lithium, the prototypical mood stabilizer, and quetiapine, a second-generation
antipsychotic, are widely used acute and maintenance pharmacotherapies for bipolar …

In this study, designed to evaluate the efficacy of lurasidone as adjunctive therapy with
lithium or valproate, patients with bipolar I depression were randomized to 6 weeks of …

Background Bipolar disorder type I (BD-I) is a chronic condition characterized by mania
episodes followed by syndromic recovery periods, usually permeated by depressive …

Aims The aim of this study was to describe the treatment of bipolar disorder patients in
psychiatric private practices in Germany in 2009 and 2018. Methods This retrospective study …

Evidence supporting the use of second generation antipsychotics (SGAs) in the treatment of
acute depression with mixed features (MFs) associated with bipolar disorder (BD) is scarce …